$CYDY
CytoDyn Inc.

2018 Q4 Form 10-K Financial Statement

#000119312518229738 Filed on July 27, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.660M $2.000M $2.190M
YoY Change 65.22% 27.39% 3.79%
% of Gross Profit
Research & Development $12.87M $11.40M $8.920M
YoY Change 41.78% 39.95% 59.29%
% of Gross Profit
Depreciation & Amortization $150.0K $90.00K $90.00K
YoY Change 66.67% 0.0% 0.0%
% of Gross Profit
Operating Expenses $15.69M $13.49M $11.20M
YoY Change 45.59% 37.54% 43.56%
Operating Profit -$15.69M -$13.49M
YoY Change 45.59% 37.54%
Interest Expense $1.727M $178.4K $393.7K
YoY Change 72.2% -87.78% -59.41%
% of Operating Profit
Other Income/Expense, Net $830.0K -$361.9K $1.967M
YoY Change -32.47% -9788.86% 102.78%
Pretax Income -$17.13M -$14.41M -$9.620M
YoY Change 56.49% 23.95% 40.85%
Income Tax -$2.827M $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.31M -$14.41M -$9.624M
YoY Change 30.67% 23.95% 40.91%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$55.23K -$65.92K -$45.34K
COMMON SHARES
Basic Shares Outstanding 292.9M shares 255.8M shares 218.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $770.0K $4.750M $1.230M
YoY Change -40.77% 400.0% -30.9%
Cash & Equivalents $772.4K $4.749M $1.231M
Short-Term Investments
Other Short-Term Assets $3.160M $2.790M $2.090M
YoY Change -8.14% -16.47% -51.95%
Inventory
Prepaid Expenses $200.9K $338.4K $227.2K
Receivables
Other Receivables
Total Short-Term Assets $3.928M $7.540M $3.321M
YoY Change -17.04% 76.07% -45.75%
LONG-TERM ASSETS
Property, Plant & Equipment $10.13K $12.04K $11.23K
YoY Change -27.85% -23.09% -35.03%
Goodwill
YoY Change
Intangibles $16.45M $1.480M $1.567M
YoY Change 844.39% -19.13% -18.26%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $16.46M $1.492M $1.578M
YoY Change 837.42% -19.17% -18.41%
TOTAL ASSETS
Total Short-Term Assets $3.928M $7.540M $3.321M
Total Long-Term Assets $16.46M $1.492M $1.578M
Total Assets $20.39M $9.031M $4.899M
YoY Change 214.15% 47.39% -39.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.85M $20.71M $15.84M
YoY Change 94.02% 265.28% 270.03%
Accrued Expenses $930.0K $970.0K $57.98K
YoY Change -42.59% 3.19% -92.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.200M $2.460M $0.00
YoY Change -22.08% -45.21% -100.0%
Total Short-Term Liabilities $23.98M $24.14M $16.73M
YoY Change 43.32% 117.31% 172.35%
LONG-TERM LIABILITIES
Long-Term Debt $1.400M $2.620M $0.00
YoY Change
Other Long-Term Liabilities $3.080M $2.070M $1.320M
YoY Change 20.78% -38.76% -56.15%
Total Long-Term Liabilities $4.472M $4.690M $1.324M
YoY Change 75.53% 38.85% -56.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.98M $24.14M $16.73M
Total Long-Term Liabilities $4.472M $4.690M $1.324M
Total Liabilities $28.45M $28.83M $18.06M
YoY Change 47.58% 99.02% 97.16%
SHAREHOLDERS EQUITY
Retained Earnings -$201.9M -$187.6M -$173.1M
YoY Change 38.67% 39.32% 40.78%
Common Stock $290.8K $233.9K $216.9K
YoY Change 76.1% 53.1% 45.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.064M -$19.80M -$13.16M
YoY Change
Total Liabilities & Shareholders Equity $20.39M $9.031M $4.899M
YoY Change 214.15% 47.39% -39.18%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$14.31M -$14.41M -$9.624M
YoY Change 30.67% 23.95% 40.91%
Depreciation, Depletion And Amortization $150.0K $90.00K $90.00K
YoY Change 66.67% 0.0% 0.0%
Cash From Operating Activities -$17.22M -$8.971M -$6.980M
YoY Change 192.36% 28.15% -2.51%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $2.262K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$2.262K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $8.990M
YoY Change 0.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.25M 12.49M 3.260M
YoY Change 112.34% 102.42% 183.48%
NET CHANGE
Cash From Operating Activities -17.22M -8.971M -6.980M
Cash From Investing Activities 0.000 -2.262K 0.000
Cash From Financing Activities 13.25M 12.49M 3.260M
Net Change In Cash -3.970M 3.518M -3.720M
YoY Change -1234.29% -524.19% -38.1%
FREE CASH FLOW
Cash From Operating Activities -$17.22M -$8.971M -$6.980M
Capital Expenditures $0.00 $2.262K $0.00
Free Cash Flow -$17.22M -$8.973M -$6.980M
YoY Change 192.36% 28.18% -2.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2010Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
375000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2018Q1 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
300000
CY2018Q1 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
400000
CY2018Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3027263 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1050060
CY2015Q2 us-gaap Convertible Debt
ConvertibleDebt
4862257
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-10692516
CY2016Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
63307150 shares
CY2015Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
5538335
CY2015Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
31008915 shares
CY2015Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.88
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9641776
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
69100000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
10205450
CY2016Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
9863492
CY2016Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.83
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4281204
CY2017Q2 us-gaap Assets
Assets
8055438
CY2017Q2 us-gaap Assets Current
AssetsCurrent
6120938
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
121736921
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1775583
CY2017Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1500000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149468244 shares
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149468244 shares
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
149468
CY2017Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1058611
CY2017Q2 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
37371817
CY2017Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32530436
CY2017Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
31072
CY2017Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3014667
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4284246
CY2017Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
216645
CY2017Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
37371817
CY2017Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
95600000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
637190
CY2017Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
3014667
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1618770
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3014667
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1881230
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1917219
CY2017Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2017Q2 us-gaap Liabilities
Liabilities
9158672
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8055438
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6144005
CY2017Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
207314
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
92
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17281
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122989715
CY2017Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
3014667
CY2017Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3014667
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-1103234
CY2017Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
4138041
CY2017Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
1300
CY2017Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
167000
CY2017Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
40250
CY2017Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2017Q2 cydy Deferred Tax Assets Tax Deferred Capitalized Debt Issuance Costs
DeferredTaxAssetsTaxDeferredCapitalizedDebtIssuanceCosts
157992
CY2017Q2 cydy Deferred Tax Assets Charitable Contributions
DeferredTaxAssetsCharitableContributions
25500
CY2017Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
186772
CY2017Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
77859626 shares
CY2017Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.86
CY2017Q4 dei Entity Public Float
EntityPublicFloat
89898278
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
15841859
CY2018Q2 us-gaap Assets
Assets
4898998
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57983
CY2018Q2 us-gaap Assets Current
AssetsCurrent
3320627
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
159764611
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1231445
CY2018Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1100000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
375000000 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
216722779 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
216881790 shares
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
216881
CY2018Q2 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
36665263
CY2018Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29230279
CY2018Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4260470
CY2018Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1323732
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2916585
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
117880
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36665263
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
139200000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
699795
CY2018Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
1323732
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1968846
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1531154
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1567143
CY2018Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
350000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
350000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1323732
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
350000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
350000
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
350000
CY2018Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
35989
CY2018Q2 us-gaap Liabilities
Liabilities
18056969
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4898998
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16733237
CY2018Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1323732
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1323732
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
227173
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
92
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11228
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-173139396
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2018Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
159
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13157971
CY2018Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
159011 shares
CY2018Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1862009
CY2018Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
174
CY2018Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
133600
CY2018Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
3673
CY2018Q2 cydy Placement Agent Warrants Fair Value
PlacementAgentWarrantsFairValue
819200
CY2018Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2018Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
139875
CY2018Q2 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
3673
CY2018Q2 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
128872852 shares
CY2018Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
132385269 shares
CY2018Q2 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.80
CY2018Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.80
CY2018Q2 cydy Treasury Stock Par Value
TreasuryStockParValue
0.001
CY2018Q2 cydy Potential Royalty Payment As Percentage Of Net Sales
PotentialRoyaltyPaymentAsPercentageOfNetSales
0.02 pure
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
218692779 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0182 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.36 pure
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018Q1 us-gaap Payments For Fees
PaymentsForFees
73000
CY2018Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1500000
CY2018Q1 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
400000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0148 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.19 pure
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
cydy Tax Cuts And Jobs Act Of2017 Blended Tax Rate
TaxCutsAndJobsActOf2017BlendedTaxRate
0.2862 pure
CY2017Q1 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
72000
CY2017Q1 cydy Class Of Warrants Or Rights Issued Expiration Date Extended
ClassOfWarrantsOrRightsIssuedExpirationDateExtended
2017-05-31
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2015 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P2Y11M9D
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
72434
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
77859626 shares
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1204791
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7866193
CY2017 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
91389
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
366385
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2164533
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.357 pure
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0010 pure
CY2017 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2164533
CY2017 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.19
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1504712
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6758606
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
15167
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25763801
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017 us-gaap Interest Expense
InterestExpense
612767
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2492789
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11114
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18877389
CY2017 us-gaap Operating Expenses
OperatingExpenses
27330734
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26732468
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-25763801
CY2017 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1150000
CY2017 cydy Interest Expense Related To Derivative Liability
InterestExpenseRelatedToDerivativeLiability
540330
CY2017 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
72437
CY2017 cydy Adjustments To Additional Paid In Capital Legal Fee With Registered Offerings
AdjustmentsToAdditionalPaidInCapitalLegalFeeWithRegisteredOfferings
-280883
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11114
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-27330734
CY2017 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1804249
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
397883
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20205743
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1204791
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
138004461 shares
CY2017 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
14044252
CY2017 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Equity Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToEquityOffering
-1804249
CY2017 cydy Adjustments To Additional Paid In Capital Debt Discounts On Convertible Notes Payable
AdjustmentsToAdditionalPaidInCapitalDebtDiscountsOnConvertibleNotesPayable
91389
CY2017 cydy Non Cash Finance Cost Associated With Investors Warrants
NonCashFinanceCostAssociatedWithInvestorsWarrants
819200
CY2017 cydy Interest Expense On Conversion Inducement
InterestExpenseOnConversionInducement
72437
CY2017 cydy Non Cash Derivative Liability Associated With Warrants
NonCashDerivativeLiabilityAssociatedWithWarrants
5179200
CY2017 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
19133755
CY2017 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
1470000 shares
CY2017 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
16935437 shares
CY2017 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
912961 shares
CY2017 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y4M24D
CY2017 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.55
CY2017 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.99
CY2017 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.75
CY2017 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.56
CY2017 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.0100 pure
CY2017 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.0280 pure
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
435609
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1666017
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
826252
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132385269 shares
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1290777
CY2018 cydy Stock Issued During Period Value Warrant Exercised
StockIssuedDuringPeriodValueWarrantExercised
3161132
CY2018 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
826252
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-544138
CY2018 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
1574628
CY2018 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
435609
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
356128
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Type
DocumentType
10-K
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2018 dei Entity Registrant Name
EntityRegistrantName
CYTODYN INC.
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1690935
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.286 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.003 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.011 pure
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-05-31
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.348 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0010 pure
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.044 pure
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1690935
CY2018 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.29
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12365959
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7340605
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
3620
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50149681
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018 us-gaap Interest Expense
InterestExpense
5924923
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2256173
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
251315
CY2018 us-gaap Interest Paid Net
InterestPaidNet
9157
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29353833
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
102064
CY2018 us-gaap Operating Expenses
OperatingExpenses
45919313
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29897971
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-50149681
CY2018 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4888500
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8990000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-45919313
CY2018 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3558789
CY2018 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Reclassifications</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the 2018 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total stockholders&#x2019; (deficit) equity, net loss or earnings per share.</p> </div>
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1010000
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
259157
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3161131
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0084 pure
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.25
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38222580
CY2018 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
13611419
CY2018 cydy Adjustments To Additional Paid In Capital Debt Discounts On Convertible Notes Payable
AdjustmentsToAdditionalPaidInCapitalDebtDiscountsOnConvertibleNotesPayable
1645011
CY2018 cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
70383
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6148 pure
CY2018 cydy Proceeds From Issuance Of Common Stock Allocated To Expense
ProceedsFromIssuanceOfCommonStockAllocatedToExpense
241986
CY2018 cydy Interest Expense Convertible Notes
InterestExpenseConvertibleNotes
2352045
CY2018 cydy Common Stock Issuance Cost Incurred
CommonStockIssuanceCostIncurred
577214
CY2018 cydy Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
17497051
CY2018 cydy Interest Expense On Inducement Related To Convertible Notes
InterestExpenseOnInducementRelatedToConvertibleNotes
2352045
CY2018 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
25224212
CY2018 cydy Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
10000000
CY2018 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
159011 shares
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1290777
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1M
CY2018 us-gaap Stock Issued1
StockIssued1
242158
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
104546
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
174885422 shares
CY2018 dei Trading Symbol
TradingSymbol
CYDY
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
5788500
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
260190
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>Use of Estimates</b></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
CY2018 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
17643451
CY2018 cydy Deferred Debt Issuance Costs
DeferredDebtIssuanceCosts
400000
CY2018 cydy Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
1666017
CY2018 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
4572321 shares
CY2018 cydy Warrants Issued Included In Closing Costs
WarrantsIssuedIncludedInClosingCosts
1066667 shares
CY2018 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
65420227 shares
CY2018 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
6322263 shares
CY2018 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm
P3Y8M
CY2018 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y9M11D
CY2018 cydy Asset Purchase Agreement Aggregate Consideration Paying Period
AssetPurchaseAgreementAggregateConsiderationPayingPeriod
P10Y
CY2018 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.50
CY2018 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.75
CY2018 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
0.50
CY2018 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2018 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.94
CY2018 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.0200 pure
CY2018 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.001 pure
CY2018 cydy Tax Cuts And Jobs Act Of2017 Blended Tax Rate
TaxCutsAndJobsActOf2017BlendedTaxRate
0.286 pure
CY2018 cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.00 pure
CY2018 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.0100 pure
CY2018 cydy Interest Related To Warrant Tender Offer
InterestRelatedToWarrantTenderOffer
393685
CY2018 cydy Adjustment To Additional Paid In Capital Stock Issued For Board Compensation
AdjustmentToAdditionalPaidInCapitalStockIssuedForBoardCompensation
260190
CY2018 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Private Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToPrivateOffering
-1717597
CY2018 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Direct Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToDirectOffering
-857149
CY2018 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
-533436
CY2018 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Warrant Tender Offer
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToWarrantTenderOffer
-85382
CY2018 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Warrant Tender Offer
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToWarrantTenderOffer
393685
CY2018 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Conversion Of Note Payable
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToConversionOfNotePayable
2352045
CY2018 cydy Stock Issued During Period Value Issued For Accrued Bonus Compensation
StockIssuedDuringPeriodValueIssuedForAccruedBonusCompensation
214263
CY2018 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
-0.002 pure
CY2018 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
0.041 pure
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
604625
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1791967
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
63307150 shares
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2353194
CY2016 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3915127
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8591716
CY2016 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
604625
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
361610
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.00 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.329 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0050 pure
CY2016 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
646505
CY2016 us-gaap Gain Loss On Non Recourse Debt
GainLossOnNonRecourseDebt
-72898
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-584177
CY2016 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.27
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5412640
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7082475
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
7918
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25703612
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016 us-gaap Interest Expense
InterestExpense
4671245
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
864817
CY2016 us-gaap Interest Expense Debt
InterestExpenseDebt
118709
CY2016 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
94344
CY2016 us-gaap Interest Paid Net
InterestPaidNet
26890
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11949
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33414316
CY2016 us-gaap Operating Expenses
OperatingExpenses
21175511
CY2018Q1 us-gaap Interest Expense
InterestExpense
3069189
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24810651
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-25703612
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11949
CY2016 us-gaap Noninterest Expense Commission Expense
NoninterestExpenseCommissionExpense
108000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-21175511
CY2016 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3915127
CY2016 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1500000
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
789140
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
548619
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13731426
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2353194
CY2016 us-gaap Stock Issued1
StockIssued1
143479
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95437594 shares
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
7947342
CY2016 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
866713
CY2016 cydy Interest Expense On Conversion Inducement
InterestExpenseOnConversionInducement
1954108
CY2016 cydy Accounts Payable Extinguished Through Settlements
AccountsPayableExtinguishedThroughSettlements
72898
CY2016 cydy Interest Expense On Inducement Related To Convertible Notes
InterestExpenseOnInducementRelatedToConvertibleNotes
1194887
CY2016 cydy Amortization Of Discounts And Premiums On Debt Notes Net
AmortizationOfDiscountsAndPremiumsOnDebtNotesNet
329524
CY2016 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
37569964
CY2016 cydy Amortization Of Debt Discounts
AmortizationOfDebtDiscounts
1791967
CY2016 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
490000 shares
CY2016 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
33838536 shares
CY2016 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
1050301 shares
CY2016 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y2M12D
CY2016 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.70
CY2016 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.80
CY2016 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.01
CY2016 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.0100 pure
CY2016 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.0090 pure
CY2016 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
-0.008 pure
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
5049037
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-5046835
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2202
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2017Q1 us-gaap Interest Expense
InterestExpense
72437
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
8016917
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-8112432
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23078
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-17950100
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-740404
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
14140507
CY2016Q4 us-gaap Interest Expense
InterestExpense
2371025
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
2893779
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-5264593
CY2016Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
211
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q4 us-gaap Interest Expense
InterestExpense
540330
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
6156117
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-5467333
CY2017Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1229114
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2018Q4 us-gaap Interest Expense
InterestExpense
1002656
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
10775051
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-10947685
CY2018Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
830022
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2016Q3 us-gaap Interest Expense
InterestExpense
2300220
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
6657481
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-8895015
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
62686
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
7799580
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-6829651
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
969929
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
5358120
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-5354385
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3735
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2018Q2 us-gaap Interest Expense
InterestExpense
393685
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
11196754
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-9623623
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1966816
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2018Q3 us-gaap Interest Expense
InterestExpense
1459393
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
9807001
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-11628273
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-361879
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
6575214
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-6497169
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
78045

Files In Submission

Name View Source Status
0001193125-18-229738-index-headers.html Edgar Link pending
0001193125-18-229738-index.html Edgar Link pending
0001193125-18-229738.txt Edgar Link pending
0001193125-18-229738-xbrl.zip Edgar Link pending
cydy-20180531.xml Edgar Link completed
cydy-20180531.xsd Edgar Link pending
cydy-20180531_cal.xml Edgar Link unprocessable
cydy-20180531_def.xml Edgar Link unprocessable
cydy-20180531_lab.xml Edgar Link unprocessable
cydy-20180531_pre.xml Edgar Link unprocessable
d840102d10k.htm Edgar Link pending
d840102dex23.htm Edgar Link pending
d840102dex24.htm Edgar Link pending
d840102dex311.htm Edgar Link pending
d840102dex312.htm Edgar Link pending
d840102dex32.htm Edgar Link pending
d840102dex411.htm Edgar Link pending
d840102dex412.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g840102dsp30.jpg Edgar Link pending
g840102g48q02.gif Edgar Link pending
g840102g75m93.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending